Skip to main content
. 2021 Aug 10;136:104759. doi: 10.1016/j.compbiomed.2021.104759

Fig. 8.

Fig. 8

RBD-AVP 1795. (a) Interacting RBD residues; (b) Interacting AVP 1795 residues; (c) Distribution of non-covalent interactions; (d) Representative snapshot (at 150 ns); AVP 1795 (purple) and RBD (grey) over 150 ns MD simulation. Arrows mark ≥90% time participation in bond formation during MD simulation.